慢性痒疹的诊断及分型新进展

doi:10.35541/cjd.20210130

Abstract

Abstract: 【Abstract】 Chronic prurigo is an independent chronic inflammatory skin disease, and complex underlying etiologies or comorbidities may exist in patients. Diagnosis of chronic prurigo requires a systematic process, including identifying core symptoms, taking a comprehensive medical history, performing physical examination, completing necessary laboratory or imaging tests, and assessing disease severity. Treatments of chronic prurigo include management of possible causes and comorbidities, and stepwise control of pruritus. This review mainly summarizes clinical diagnosis, classification and treatment of chronic prurigo.

Key words: Prurigo, Pruritus, Diagnosis, Clinical types, Chronic prurigo

Cheng Bihong, Dou Xia. Diagnosis and classification of chronic prurigo[J]. Chinese Journal of Dermatology, 2023, 56(11): 1070-1073.doi:10.35541/cjd.20210130

References ［44］

［1］	Pereira MP, Basta S, Moore J, et al. Prurigo nodularis: a physician survey to evaluate current perceptions of its classification, clinical experience and unmet need［J］. J Eur Acad Dermatol Venereol, 2018,32（12）:2224⁃2229. doi: 10.1111/jdv.15107.
［2］	Pereira MP, Zeidler C, Wallengren J, et al. Chronic nodular prurigo: a European cross⁃sectional study of patient perspectives on therapeutic goals and satisfaction［J］. Acta Derm Venereol, 2021,101（2）:adv00403. doi: 10.2340/00015555⁃3726.
［3］	Pereira MP, Hoffmann V, Weisshaar E, et al. Chronic nodular prurigo: clinical profile and burden. A European cross⁃sectional study［J］. J Eur Acad Dermatol Venereol, 2020,34（10）:2373⁃2383. doi: 10.1111/jdv.16309.
［4］	Huang AH, Canner JK, Khanna R, et al. Real⁃world prevalence of prurigo nodularis and burden of associated diseases［J］. J Invest Dermatol, 2020,140（2）:480⁃483.e4. doi: 10.1016/j.jid. 2019.07.697.
［5］	Pereira MP, Steinke S, Zeidler C, et al. European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo［J］. J Eur Acad Dermatol Venereol, 2018,32（7）:1059⁃1065. doi: 10.1111/jdv.14570.
［6］	Kwatra SG. Breaking the itch⁃scratch cycle in prurigo nodularis［J］. N Engl J Med, 2020,382（8）:757⁃758. doi: 10.1056/NEJMe 1916733.
［7］	Park K, Mori T, Nakamura M, et al. Increased expression of mRNAs for IL⁃4, IL⁃17, IL⁃22 and IL⁃31 in skin lesions of subacute and chronic forms of prurigo［J］. Eur J Dermatol, 2011,21（1）:135⁃136. doi: 10.1684/ejd.2010.1196.
［8］	Wong LS, Yen YT, Lin SH, et al. IL⁃17A induces endothelin⁃1 expression through p38 pathway in prurigo nodularis［J］. J Invest Dermatol, 2020,140（3）:702⁃706.e2. doi: 10.1016/j.jid. 2019.08.438.
［9］	Belzberg M, Alphonse MP, Brown I, et al. Prurigo nodularis is characterized by systemic and cutaneous T helper 22 immune polarization［J］. J Invest Dermatol, 2021,141（9）:2208⁃2218.e14. doi: 10.1016/j.jid.2021.02.749.
［10］	Oetjen LK, Mack MR, Feng J, et al. Sensory neurons co⁃opt classical immune signaling pathways to mediate chronic itch［J］. Cell, 2017,171（1）:217⁃228.e13. doi: 10.1016/j.cell.2017.08.006.
［11］	Zhong W, Wu X, Zhang W, et al. Aberrant expression of histamine⁃independent pruritogenic mediators in keratinocytes may be involved in the pathogenesis of prurigo nodularis［J］. Acta Derm Venereol, 2019,99（6）:579⁃586. doi: 10.2340/0001 5555⁃3150.
［12］	Pogatzki⁃Zahn EM, Pereira MP, Cremer A, et al. Peripheral sensitization and loss of descending inhibition is a hallmark of chronic pruritus［J］. J Invest Dermatol, 2020,140（1）:203⁃211.e4. doi: 10.1016/j.jid.2019.05.029.
［13］	Schuhknecht B, Marziniak M, Wissel A, et al. Reduced intraepidermal nerve fibre density in lesional and nonlesional prurigo nodularis skin as a potential sign of subclinical cutaneous neuropathy［J］. Br J Dermatol, 2011,165（1）:85⁃91. doi: 10.1111/j.1365⁃2133.2011.10306.x.
［14］	Ohanyan T, Schoepke N, Eirefelt S, et al. Role of substance P and its receptor neurokinin 1 in chronic prurigo: a randomized, proof⁃of⁃concept, controlled trial with topical aprepitant［J］. Acta Derm Venereol, 2018,98（1）:26⁃31. doi: 10.2340/00015555⁃2780.
［15］	Brune A, Metze D, Luger TA, et al. Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non⁃placebo controlled administration in 133 patients［J］. Hautarzt, 2004,55（12）:1130⁃1136. doi: 10.1007/s00105⁃004⁃0802⁃8.
［16］	Schedel F, Schürmann C, Metze D, et al. Prurigo. Clinical definition and classification［J］. Hautarzt, 2014,65（8）:684⁃690. doi: 10.1007/s00105⁃014⁃2753⁃z.
［17］	Pereira MP, Zeidler C, Nau T, et al. Position statement: linear prurigo is a subtype of chronic prurigo［J］. J Eur Acad Dermatol Venereol, 2019,33（2）:263⁃266. doi: 10.1111/jdv.15275.
［18］	Wallengren J. Prurigo: diagnosis and management［J］. Am J Clin Dermatol, 2004,5（2）:85⁃95. doi: 10.2165/00128071⁃200405020⁃00003.
［19］	Huang AH, Williams KA, Kwatra SG. Prurigo nodularis: epidemiology and clinical features［J］. J Am Acad Dermatol, 2020,83（6）:1559⁃1565. doi: 10.1016/j.jaad.2020.04.183.
［20］	Whang KA, Mahadevan V, Bakhshi PR, et al. Prevalence of prurigo nodularis in the United States［J］. J Allergy Clin Immunol Pract, 2020,8（9）:3240⁃3241. doi: 10.1016/j.jaip.2020.05.051.
［21］	Ständer S, Yosipovitch G, Legat FJ, et al. Trial of nemolizumab in moderate⁃to⁃severe prurigo nodularis［J］. N Engl J Med, 2020,382（8）:706⁃716. doi: 10.1056/NEJMoa1908316.
［22］	Gore Karaali M, Erdil D, Erdemir VA, et al. Evaluation of clinicopathological and treatment characteristics of 80 patients with acquired perforating dermatosis［J/OL］. Dermatol Ther, 2020,33（6）:e14465. doi: 10.1111/dth.14465.
［23］	Kestner RI, Ständer S, Osada N, et al. Acquired reactive perforating dermatosis is a variant of prurigo nodularis［J］. Acta Derm Venereol, 2017,97（2）:249⁃254. doi: 10.2340/00015555⁃2492.
［24］	韩毓梅, 胡东艳, 李明, 等. 17例获得性反应性穿通性胶原病临床分析［J］. 中国麻风皮肤病杂志, 2018,34（12）:728⁃731.
［25］	Brenaut E, Halvorsen JA, Dalgard FJ, et al. The self⁃assessed psychological comorbidities of prurigo in European patients: a multicentre study in 13 countries［J］. J Eur Acad Dermatol Venereol, 2019,33（1）:157⁃162. doi: 10.1111/jdv.15145.
［26］	Pereira MP, Ständer S. How to define chronic prurigo?［J］. Exp Dermatol, 2019,28（12）:1455⁃1460. doi: 10.1111/exd.13972.
［27］	Ständer HF, Elmariah S, Zeidler C, et al. Diagnostic and treatment algorithm for chronic nodular prurigo［J］. J Am Acad Dermatol, 2020,82（2）:460⁃468. doi: 10.1016/j.jaad.2019.07.022.
［28］	Elmariah S, Kim B, Berger T, et al. Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus［J］. J Am Acad Dermatol, 2021,84（3）:747⁃760. doi: 10.1016/j.jaad.2020.07.025.
［29］	Zeidler C, Pereira MP, Dugas M, et al. The burden in chronic prurigo: patients with chronic prurigo suffer more than patients with chronic pruritus on non⁃lesional skin: a comparative, retrospective, explorative statistical analysis of 4,484 patients in a real⁃world cohort［J］. J Eur Acad Dermatol Venereol, 2021,35（3）:738⁃743. doi: 10.1111/jdv.16929.
［30］	Kwon CD, Khanna R, Williams KA, et al. Diagnostic workup and evaluation of patients with prurigo nodularis［J］. Medicines （Basel）, 2019,6（4）:97. doi: 10.3390/medicines6040097.
［31］	Werbel T, Hinds BR, Cohen PR. Scabies presenting as cutaneous nodules or malar erythema: reports of patients with scabies surrepticius masquerading as prurigo nodularis or systemic lupus erythematosus［J/OL］. Dermatol Online J, 2018,24（9）:13030/qt5bn8k4vx.
［32］	Weigelt N, Metze D, Ständer S. Prurigo nodularis: systematic analysis of 58 histological criteria in 136 patients［J］. J Cutan Pathol, 2010,37（5）:578⁃586. doi: 10.1111/j.1600⁃0560.2009. 01484.x.
［33］	朱学骏, 涂平, 陈喜雪, 等. 皮肤病的组织病理学诊断［M］. 3版. 北京: 北京大学医学出版社, 2016:63, 92⁃93.
［34］	Ständer S, Holtsche MM, Schmidt E, et al. Presence of cutaneous complement deposition distinguishes between immunological and histological features of bullous pemphigoid⁃insights from a retrospective cohort study［J］. J Clin Med, 2020,9（12）:3928. doi: 10.3390/jcm9123928.
［35］	Abdel⁃Latif AA, Elshahed AR, Salama OA, et al. Comparing the diagnostic properties of skin scraping, adhesive tape, and dermoscopy in diagnosing scabies［J］. Acta Dermatovenerol Alp Pannonica Adriat, 2018,27（2）:75⁃78. doi: 10.15570/actaapa.2018. 17.
［36］	Hanumaiah B, Joseph JM. Role of dermoscopy in the diagnosis of hypertrophic lichen planus and prurigo nodularis［J］. Indian J Dermatol, 2019,64（5）:341⁃345. doi: 10.4103/ijd.IJD_123_18.
［37］	Li FZ, Chen S. Diagnostic accuracy of dermoscopy for scabies［J］. Korean J Parasitol, 2020,58（6）:669⁃674. doi: 10.3347/kjp. 2020.58.6.669.
［38］	Zeidler C, Pereira MP, Augustin M, et al. Investigator′s global assessment of chronic prurigo: a new instrument for use in clinical trials［J］. Acta Derm Venereol, 2021,101（2）:adv00401. doi: 10.2340/00015555⁃3701.
［39］	Pölking J, Zeidler C, Schedel F, et al. Prurigo activity score （PAS）: validity and reliability of a new instrument to monitor chronic prurigo［J］. J Eur Acad Dermatol Venereol, 2018,32（10）:1754⁃1760. doi: 10.1111/jdv.15040.
［40］	Boozalis E, Tang O, Patel S, et al. Ethnic differences and comorbidities of 909 prurigo nodularis patients［J］. J Am Acad Dermatol, 2018,79（4）:714⁃719.e3. doi: 10.1016/j.jaad.2018.04. 047.
［41］	Larson VA, Tang O, Stander S, et al. Association between prurigo nodularis and malignancy in middle⁃aged adults［J］. J Am Acad Dermatol, 2019,81（5）:1198⁃1201. doi: 10.1016/j.jaad.2019.03. 083.
［42］	Huang AH, Canner JK, Kang S, et al. Analysis of real⁃world treatment patterns in patients with prurigo nodularis［J］. J Am Acad Dermatol, 2020,82（1）:34⁃36. doi: 10.1016/j.jaad.2019.09. 007.
［43］	Agelopoulos K, Rülander F, Dangelmaier J, et al. Neurokinin 1 receptor antagonists exhibit peripheral effects in prurigo nodularis including reduced ERK1/2 activation［J］. J Eur Acad Dermatol Venereol, 2019,33（12）:2371⁃2379. doi: 10.1111/jdv. 15905.
［44］	Chiricozzi A, Maurelli M, Gori N, et al. Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo［J］. J Am Acad Dermatol, 2020,83（1）:39⁃45. doi: 10.1016/j.jaad.2020.03.049.

[1]	Wang Yuqian, Qiao Jianjun, Fang Hong. Comparison of the latest Chinese and international guidelines/consensus on diagnosis and treatment of alopecia areata [J]. Chinese Journal of Dermatology, 2023, 56(9): 885-888.
[2]	Yuan Xingang, Ni Sili, Zhang Jian, Luo Xiaoyan, Wang Hua. Improving diagnosis and treatment of melanocytic nevi in children: an urgent need [J]. Chinese Journal of Dermatology, 2023, 56(8): 782-786.
[3]	Committee on Psoriasis, Chinese Society of Dermatology. Guideline for the diagnosis and treatment of psoriasis in China （2023 edition） [J]. Chinese Journal of Dermatology, 2023, 56(7): 573-625.
[4]	Mi Shuhong, Yu Yanqin, Hao Jinqi, Li Wei, Zhang Yang, Jia Ximei, Huang Yuxian, Sun Huaiyu, Shi Jihai. Analysis of imaging characteristics of papulopustular rosacea by high-frequency ultrasound combined with color Doppler flow imaging [J]. Chinese Journal of Dermatology, 2023, 56(6): 540-544.
[5]	Liang Yunsheng, Li Zhanhong, Wu Yibei. Progress in the treatment of chronic spontaneous urticaria: insights from the changes in the understanding of its pathogenesis [J]. Chinese Journal of Dermatology, 2023, 56(6): 552-558.
[6]	Chen Qiquan, Yang Xianjie, Wang Wenwen, Liang Gaopeng, Song Zhiqiang . Development and application of clinical assessment tools for cholinergic urticaria [J]. Chinese Journal of Dermatology, 2023, 56(6): 563-566.
[7]	Chen Qiquan, Yang Xianjie, Gu Heng, Xu Jinhua, Hao Fei, Yao Xu, Song Zhiqiang. Construction of “Expert consensus on diagnosis and treatment of chronic inducible urticaria in China （2023）” based on the Delphi method [J]. Chinese Journal of Dermatology, 2023, 56(6): 534-539.
[8]	Immunology Group, Chinese Society of Dermatology. Expert consensus on diagnosis and treatment of chronic inducible urticaria in China （2023） [J]. Chinese Journal of Dermatology, 2023, 56(6): 479-488.
[9]	Hu Qingjie, Zhou Min, Yao Xu. Analysis of clinical characteristics of 36 patients with pyoderma gangrenosum and comparison between the PARACELSUS score and Delphi criteria for their diagnosis [J]. Chinese Journal of Dermatology, 2023, 56(5): 410-414.
[10]	Committee on Sexually Transmitted Diseases, China Dermatologist Association. Expert consensus on clinical management of serofast state in syphilis （2023） [J]. Chinese Journal of Dermatology, 2023, 56(5): 383-388.
[11]	Wang Min, He Pingxiu, Cheng Lifang, Hong Kechun, Ai Yong. A case of meningothelial hamartoma of the scalp [J]. Chinese Journal of Dermatology, 2023, 56(5): 449-450.
[12]	Jia Weixue, Li Chengrang. Comparison of Chinese and international guidelines and consensus for the diagnosis and treatment of vitiligo [J]. Chinese Journal of Dermatology, 2023, 56(5): 471-475.
[13]	Luo Shuaihantian, Long Hai, Lu Qianjin, . Research advances in systemic lupus erythematosus in 2022 [J]. Chinese Journal of Dermatology, 2023, 56(3): 266-269.
[14]	Xie yuanyuan, Liu Yuzhen, Zeng Rong, . Application of skin imaging techniques in acne vulgaris [J]. Chinese Journal of Dermatology, 2023, 0(2): 20230100-e20230100.
[15]	Chen Qitao, Li Yuqian, Shao Guanghui, Zhu Jing, Zhu Qilin, Li Zhongming, Du Xufeng, Fan Weixin. Erosive pustular dermatosis of the scalp [J]. Chinese Journal of Dermatology, 2023, 0(2): 20210803-e20210803.

Diagnosis and classification of chronic prurigo

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［44］

Related Articles 15

Metrics

Comments

Recommended 10